Rhea M Shields

Array ( [id] => 10887981 [patent_doc_number] => 08911976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Lignin-based enzyme stabilizer' [patent_app_type] => utility [patent_app_number] => 13/583479 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6693 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9004352 [patent_doc_number] => 20130225477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'Oral Lactoferrin in the Treatment of Severe Sepsis' [patent_app_type] => utility [patent_app_number] => 13/580434 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18612 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152101 [patent_doc_number] => 08168587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases' [patent_app_type] => utility [patent_app_number] => 13/033344 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16993 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168587.pdf [firstpage_image] =>[orig_patent_app_number] => 13033344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5938303 [patent_doc_number] => 20110213236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'THERAPEUTIC COMPOSITIONS, DEVICES AND METHODS FOR OBSERVING TREATED TISSUES' [patent_app_type] => utility [patent_app_number] => 13/021487 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39041 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213236.pdf [firstpage_image] =>[orig_patent_app_number] => 13021487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968154 [patent_doc_number] => 08506964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis' [patent_app_type] => utility [patent_app_number] => 13/021635 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15238 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13021635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959943 [patent_doc_number] => 20110184330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'INACTIVATION OF SMOOTH MUSCLE TISSUE' [patent_app_type] => utility [patent_app_number] => 13/018713 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3681 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184330.pdf [firstpage_image] =>[orig_patent_app_number] => 13018713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112917 [patent_doc_number] => 20110190193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'TREATMENT OF ENDOTHELIAL DYSFUNCTION IN DIABETIC PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/017930 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7030 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190193.pdf [firstpage_image] =>[orig_patent_app_number] => 13017930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586827 [patent_doc_number] => 20110281337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL' [patent_app_type] => utility [patent_app_number] => 13/009813 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 55588 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281337.pdf [firstpage_image] =>[orig_patent_app_number] => 13009813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465113 [patent_doc_number] => 20120270281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'BIOREACTOR PERFORMANCE IN THE PRODUCTION OF MONATIN' [patent_app_type] => utility [patent_app_number] => 13/520027 [patent_app_country] => US [patent_app_date] => 2010-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8548 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502199 [patent_doc_number] => 20110263816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METALLOPEPTIDE CATALYSTS' [patent_app_type] => utility [patent_app_number] => 12/953075 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5763 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263816.pdf [firstpage_image] =>[orig_patent_app_number] => 12953075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9529752 [patent_doc_number] => 08753619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Tissue adhesives and sealants and methods for their use' [patent_app_type] => utility [patent_app_number] => 12/952520 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5060 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127669 [patent_doc_number] => 20110086801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'PREVENTION AND REDUCTION OF BLOOD LOSS' [patent_app_type] => utility [patent_app_number] => 12/951543 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12077 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086801.pdf [firstpage_image] =>[orig_patent_app_number] => 12951543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573112 [patent_doc_number] => 20110268768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Compositions and Methods for Treating Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/950389 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21655 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268768.pdf [firstpage_image] =>[orig_patent_app_number] => 12950389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6161623 [patent_doc_number] => 20110159572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'MICROORGANISMS FOR THE PRODUCTION OF 1,4-BUTANEDIOL' [patent_app_type] => utility [patent_app_number] => 12/947790 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 55712 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159572.pdf [firstpage_image] =>[orig_patent_app_number] => 12947790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007490 [patent_doc_number] => 20110059521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'DEVICE AND METHOD FOR MONITORING INHIBITION OF PLATELET FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/947770 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6639 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059521.pdf [firstpage_image] =>[orig_patent_app_number] => 12947770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048824 [patent_doc_number] => 20110207816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'ALTERNATE MORPHEEINS OF ALLOSTERIC PROTEINS AS A TARGET FOR THE DEVELOPMENT OF BIOACTIVE MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/942320 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 34333 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207816.pdf [firstpage_image] =>[orig_patent_app_number] => 12942320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660305 [patent_doc_number] => 20130041134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'METHODS FOR PREPARING POLYETHYLENE GLYCOL MALEIMIDE USING N-(2-HYDROXYETHYL) MALEIMIDE AS A STARTING MATERIAL' [patent_app_type] => utility [patent_app_number] => 13/505444 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5467 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048396 [patent_doc_number] => 20110207657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Selectively Targeted Antimicrobial Peptides and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/938278 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21133 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207657.pdf [firstpage_image] =>[orig_patent_app_number] => 12938278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802517 [patent_doc_number] => 08440792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Antimicrobial peptides and derived metapeptides' [patent_app_type] => utility [patent_app_number] => 12/911693 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 28304 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12911693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6161440 [patent_doc_number] => 20110159540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins' [patent_app_type] => utility [patent_app_number] => 12/910265 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25141 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159540.pdf [firstpage_image] =>[orig_patent_app_number] => 12910265 [rel_patent_id] =>[rel_patent_doc_number] =>)